acute respiratory syndrome in Wuhan, China (https://www.ncbi.nlm.nih.gov/nuccore/MN908947.1). The antiviral drug remdesivir received emergency use authorization within 5 months of publication of the viral genome (Figure 1). Remarkable progress was made throughout 2020 developing diagnostic tests, ...